An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of rabbit immunoglobulin G (IgG) antibodies to purified cell wall teichoic acids from the Staphylococcus aureus Lafferty strain and three strains of coagulase-negative staphylococci. Significant immunological cross-reactivity occurred only between the teichoic acid of S. aureus and one coagulase-negative preparation. The ELISA was used to determine the serum IgG response to Staphylococcus epidermidis in a rabbit model of aortic valve endocarditis. Blood samples were drawn before inoculation and then every 5 days until death or sacrifice at 32 to 35 days postinoculation. Valve vegetations were culture positive at autopsy in 16 (59%) of the 27 catheterized rabbits. Antibody titers in this culture-positive group and the culture-negative group began to rise as early as day 6. Although both groups demonstrated an antibody response, the culture-positive group attained a significantly higher titer on days 26 and 31. Antibodies also rose in a control group of rabbits without a heart catheter but which were inoculated with bacteria. Again, the antibody titer was significantly less than that for the culture-positive group. This ELISA may be useful for the diagnosis of coagulasenegative staphylococcal infections in humans.
teichoic acids (13) . Elevated serum levels of antibodies to ribitol teichoic acid are associated with endocarditis or other serious infections due to S. aureus (2, 11, 20) . Coagulase-negative staphylococci are increasingly recognized as pathogens in prosthetic valve endocarditis, cerebrospinal fluid shunts, and intravascular catheter infections (1, 4, 18) . The cell wall teichoic acids of coagulase-negative staphylococci contain antigenically distinct glycerol teichoic acids (13) . A similar serological assay for anti-glycerol teichoic acid antibodies may prove to be an aid in the confirmation of coagulase-negative staphylococcal infection.
The ability of an enzyme-linked immunosorbent assay (ELISA) to detect anti-teichoic acid antibodies was investigated in a rabbit model of Staphylococcus epidermidis endocarditis. Immunological cross-reaction among the glycerol teichoic acids of coagulase-negative staphylococci and the ribitol teichoic acid of S. aureus have been described by several investigators (3, 8, 10, 15) . Crowder and White (2) noted that two patients with S. epidermidis endocarditis possessed precipitins to ribitol teichoic acid of S.
aureus. Therefore, we also determined crossreactivity among three separate coagulase-negative cell wall teichoic acid preparations and S. aureus teichoic acid by an ELISA inhibition system.
(This work was presented in part at the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., 22 September 1980.) MATERIALS 
AND METHODS
Bacteria. S. epidermidis 1254 was used in the production of experimental endocarditis and as one source of teichoic acid antigen in the ELISA. This staphylococcal strain and others used in this study were obtained from Per Oeding (Bergen, Norway) by Arthur White (Indianapolis, Ind.).
In addition to strain 1254, teichoic acid antigens were prepared from reference staphylococcal strains S. epidermidis T-2, S. saprophyticus 11997, and S.
aureus Lafferty. The teichoic acids of strains 1254, T-2, and 11997 were previously described by Oeding (13) to comprise the major antigenic types found among coagulase-negative staphylococci. S. aureus Lafferty is commonly used in clinical assays for teichoic acid antibodies in patients with S. aureus infections (2) . All four strains were catalase positive. Strains 1254, T-2, and 11997 were negative for coagulase activity as determined by a tube test with EDTA-rabbit plasma, S. EPIDERMIDIS ENDOCARDITIS 1021 whereas the Lafferty strain was positive. Novobiocin susceptibility was determined by swabbing a plate of P agar with the organisms and then applying a 5-,ug novobiocin disk (BBL Microbiology Systems). The zone of inhibition was measured from the edge of the disk to the start of bacterial growth. The zones of inhibition were 10 mm for strain 1254, 10 mm for strain T-2, 6 mm for strain 11997, and 13 mm for the Lafferty strain. The coagulase-negative strains were further characterized by the Staph-Ident system (Analytab Products, Inc.). Strains 1254 and T-2 showed urea utilization but no phosphate activity; both lacked utilization of mannose, mannitol, trehalose, and salicin. Strain 11997 lacked phosphatase activity, utilized urea and mannitol, and did not utilize mannose, trehalose, and salicin.
Antisera. Antisera to the individual staphylococcal strains were produced in rabbits (12) . The immunization schedule consisted of three series of three successive days of intravenous injections (108 to 109 CFU) of whole bacteria into the marginal ear vein of the rabbit.
Each series was separated from the previous by an interval of 5 days. The rabbits were bled 7 days after the last inoculation. Sera from individual immunized rabbits without pooling were used in the immunodiffusion and ELISA inhibition studies.
Preparation of teichoic acids. The procedure of Oeding (13) was used to prepare the teichoic acid antigens. Bacteria were cultured in tryptic soy broth (Difco Laboratories) for 18 h at 37°C on a rotary shaker. The bacteria were harvested from the culture broth by continuous-flow centrifugation. The bacterial pellet was shaken with 0.067 M phosphate buffer, pH 6.5, for 24 h at 37°C and then centrifuged at 4,000 x g for 30 min to remove the remaining whole bacteria. After the pH was adjusted to 4.2 with 1.0 N HCI, the supernatant was refrigerated at 4°C for 24 h. The resulting protein precipitate was removed by centrifugation. Crude teichoic acid was precipitated from the supernatant by increasing the pH to 5.2, adding 5 volumes of ethanol, and refrigerating the mixture at 4°C for 24 h. The crude teichoic acid was then collected by centrifugation, dissolved in distilled water, and lyophilized. (17) . Crude cell walls were obtained by sonication (Branson Heat System, Inc.) of 20% suspensions of whole bacteria and glass beads in 0.1 M phosphate-buffered saline at 4°C. Glass beads and unbroken organisms were removed by centrifugation at 3,000 x g for 10 min, and the walls were pelleted by centrifugation at 25,000 x g for 20 min. The walls were washed, suspended in 2% sodium dodecyl sulfate, stirred for 16 h, washed, and then treated with DNase, RNase, and trypsin. After another wash, the walls were stirred with 40% phenol for 30 min, washed, treated with 20% trichloroacetic acid at 60°C for 90 min, washed a final three times, and lyophilized. The lyophilized preparation was used in the inhibition studies.
ELISA. The ELISA for the determination of rabbit immunoglobulin G (IgG) anti-teichoic acid antibodies was performed as originally described by Engvall and Perlmann (6) . All procedures were performed with the EIA PR-50 (Gilford Instruments). The disposable Cuvette-Pak (Gilford Instruments), composed of a polystyrene acrylic copolymer, was used as the surface for antigen coating. Each cuvette was coated with 250 ,ul of a solution containing the antigen in 0.01 M phosphate-buffered saline-0.005% thimerosal, pH 7.4. The antigen concentration for coating was determined by comparing concentrations of antigens (1.0 to 1,000.0 ,ug/ml) with the level of absorbance obtained with a range of dilute (1:256 to 1:2,048) hyperimmune rabbit serum. The optimal antigen concentration was the lowest concentration (25 ,ug/ml) yielding a maximal absorbance. Each cuvette was coated with 250 ,ul of solution containing the antigen in 0.01 M phosphatebuffered saline-0.005% thimerosal, pH 7.4. The antigen was adsorbed to the cuvette by overnight incubation at 37°C. The cuvettes were sealed to minimize evaporation.
The enzyme conjugate was the horseradish peroxi- ELISA inhibition studies. The four separate teichoic acid antigens and the Lafferty peptidoglycan were used as the absorbing antigens in ELISA inhibition studies. Antigen concentrations ranged from 0.001 to 0.250 mg/ml. The antigens were added to fixed dilutions of hyperimmune rabbit serum prepared against the four staphylococcal strains. Serial dilutions of homologous hyperimmune serum were assayed to determine the optimal dilution for inhibition. Serum dilutions which fell within the linear decrease in absorbance were chosen for the inhibition studies. Dilutions were prepared in 0.01 M phosphate-buffered saline-0.005% thimerosal, pH 7.4, and incubated overnight with absorbing antigens at 4°C. The next morning, the dilutions were centrifuged at 25,000 x g at 4°C for 15 min, and the supernatant was added to an equal volume of 0.01 M phosphate-buffered saline-0.10% Tween 20-2% bovine albumin. Portions were added to cuvettes which had been previously coated with antigen, and the ELISA was performed as usual. An unabsorbed antiserum control was run simultaneously. An inhibition system thus consisted of the assay of homologous antiserum which had been absorbed with various antigens and antigen concentrations. Percent inhibition was expressed as a percentage of unabsorbed control. Curves were calculated, and confidence limits were determined by regression and correlation analyses (5) .
Production of endocarditis. New Zealand white rabbits weighing between 1.4 and 4.0 kg were used for the production of left-sided endocarditis. Initial nonbacterial thrombotic endocarditis was produced by the introduction of an 18.5-gauge polyethylene catheter (ICath; CR Bard, Inc.) into the carotid artery and across the aortic valve. The catheter, without the inner metal guide wire, was left in place for the entire study period. The cervical portion of the catheter was tied off and buried within the neck, and the skin was sutured over it. The rabbits were anesthetized for catheter insertion with intravenous pentobarbitol or intramuscular ketamine (Ketalar). Seventy-two hours after catheterization, the rabbits were intravenously inoculated in the marginal ear vein with a 1.0-to 2.0-ml suspension of 109 CFU of bacteria. A control group of rabbits that had not had catheter insertion was inoculated intravenously.
Blood was drawn for quantitative culture and serology before inoculation, at 24 h after intravenous inoculation, and then every 5 days until sacrifice at 32 and 35 days postinoculation. Rabbits dying before the end of the study period were autopsied, and their valve vegetations were cultured qualitatively. The vegetations were washed with sterile 0.01 M phosphatebuffered saline, homogenized, and suspended in tryptic soy broth (Difco Laboratories). Vegetations from the rabbits sacrificed at the end of the study were weighed, washed, homogenized, and cultured quantitatively in tryptic soy agar pour plates. Rabbits in which the catheter was found at autopsy to be malpositioned were excluded from further study. Culture isolates were Gram stained and checked for catalase production. Coagulase production was determined by a tube coagulase test.
Culture methods. S. epidermidis 1254 was grown overnight at 37°C in tryptic soy broth before intravenous inoculation. The cultures were centrifuged, washed with sterile 0.01 M phosphate-buffered saline (pH 7.4), and inoculated intravenously into the rabbits as a 1.0-to 2.0-mi suspension. The number of CFU in each inoculum was determined by inoculating tryptic soy agar pour plates with 10-fold dilutions of the bacterial suspension. Blood samples for culture were withdrawn in 1.0-ml amounts from the central ear artery or marginal ear vein of the rabbits. Culture isolates were identified similar to isolates from valve vegetations.
Statistical analysis. Means were expressed as the geometric mean. The standard error of the mean was also calculated. Analysis of differences between groups was performed with a two-tailed Student's t test for unpaired data. The significance of differences in reciprocal log2 antibody titers at intervals postinoculation was determined for: (i) catheterized rabbits with culture-positive vegetations; (ii) catheterized rabbits which were culture negative at autopsy; and (iii) noncatheterized, inoculated rabbits.
RESULTS

Antigenic preparation and inhibition studies.
UV spectral analysis of the four teichoic acid antigens (1 mg/ml) were compared at 280 nm and 254 nm with standard dilutions of protein and nucleic acid. The teichoic acid preparations contained at least less than 1.0% protein and nucleic acids. The antigens were also analyzed by crossed immunoelectrophoresis against antiserum to whole bacteria. These studies indicated that the preparations contained a single major precipitin band. ELISA inhibition studies revealed that the teichoic acid preparations were complex, with more than a single immunodeterminant, and that each preparation possessed a distinctly different immunodeterminant. An homologous inhibition system comprised cuvettes coated with teichoic acid prepared from the strain used to raise the antiserum in the system. Thus, the strain 1254 system used 50 ,ug of strain 1254 teichoic acid per ml to coat the cuvettes, and the strain 1254 antiserum was absorbed with known concentrations of the inhibiting antigens: teichoic acids (strains 1254, T-2, 11997, and Lafferty) and strain Lafferty peptidoglycan. Table 1 shows the antigen concentrations required to achieve 50.0% inhibition in the ELISA system with antiserum to whole bacteria. The primary immunodeterminant for each system was contained in the teichoic acid antigen from the strain used to prepare the antiserum. The teichoic acid from the Lafferty strain was also able to achieve 50.0% inhibition in the strain 1254 system at the maximum concentration (0.250 mg/ml). The primary antigen in each system and strain Lafferty teichoic acid in the strain 1254 system were the only instances in which 50.0% inhibition was achieved. Although the other antigens in each system showed some inhibition, they were much (Fig. 1) .
Production of endocarditis. A total of 27 rabbits with left heart catheters were inoculated with a suspension containing a mean of 109 CFU (108-2 to 1010 CFU) of S. epidermidis 1254. Of the 27 rabbits, 17 died before the end of the study period. Positive vegetation cultures were obtained from 15 of these 17 rabbits. An additional rabbit sacrificed on day 35 was also positive. Thus, a total of 16 (59%) of the rabbits had culture-positive valvular vegetations. The mean period of survival was 20.8 days.
No bacteria were found in quantitative cultures of vegetations from 9 of the 10 rabbits that survived 31 to 35 days and from 2 of the rabbits that died before the completion of the study period. Therefore, 11 (41%) of the 27 rabbits were culture negative at autopsy.
Blood cultures were positive at 24 h in all 27 rabbits. Cultures taken on day 6 or 11 were usually negative or contained less than 4.0 CFU/ Figure 2 shows the antibody titer in the seven rabbits which received only an intravenous inoculation of strain 1254. A rise in IgG antibody titers to all four of the teichoic acid antigens began by day 6 and continued to rise until a plateau was reached on day 16 . The titer rise to the strain Lafferty antigen was greater than that to the antigens of strains 11997 and T-2 but significantly less than that to the homologous strain 1254 antigen.
Antibody response in culture-negative catheterized rabbits. There were 11 rabbits in this group. Antibody titers began to rise by day 6, with the highest titers being detected with the strain 1254 antigen (Fig. 3 ). Antibody titers with strain 1254 teichoic acid were significantly greater than antigens in 11 rabbits which were catheterized and inoculated with strain 1254 but which were culture negative at autopsy. All but two rabbits survived until sacrificed. Brackets enclose the standard error of the mean. Strains T-2 and 11997 had significantly less response than did strain Lafferty throughout the study and had less response than did strain 1254 from day 6 to the end. x, Statistically greater than strain Lafferty teichoic acid (P < 0.05).
those with strains T-2 and 11997 from day 6 throughout the remainder of the study, but greater than that with strain Lafferty only on day 31. The strain Lafferty antigen gave significantly higher titers than did strain T-2 and 11997 antigens throughout the study period.
Antibody response in culture-positive catheterized rabbits. Antibody titers to all four antigens rose by day 6, with antibodies to strain 1254 achieving the highest titers (Fig. 4) . Antibodies to strain 1254 were significantly higher than those to Lafferty antigen on days 16, 21, and 26. Strains T-2 and 11997 gave significantly lower titers than did strain Lafferty.
Antibody response to strain 1254 teichoic acid among all groups. The IgG antibody level rose sharply by day 6 in all three groups. The titer of the culture-negative and control groups did not increase after day 16, whereas the antibody titers of the culture-positive rabbits continued to rise. The culture-positive group reached a statistically higher level than did the culture-negative and control groups on days 26 and 31. Random blood drawn on a group of 32 rabbits without bacterial inoculaton revealed a geometric mean reciprocal titer of log2 5.4. with both the cell wall and cell membrane (lipoteichoic acids). Both coagulase-positive and coagulase-negative staphylococci contain glycerol teichoic acid within the cell membrane (23) . The cell wall teichoic acid of coagulase-positive staphylococci (S. aureus) is a-and/or P-N-acetylglucosamine ribitol teichoic acid. The coagulase-negative staphylococci are a much more heterogenous group. Oeding (13) considers coagulase-negative staphylococci with either a-or P-glucosyl glycerol teichoic acids as S. epidermidis and those with N-acetylglucosamine glycerol teichoic acid as S. saprophyticus. Other types and also nontypable strains of coagulasenegative staphylococci may contain these teichoic acids, especially the N-acetylglucosamine glycerol teichoic acid of strain 11997 (14) . Strain 1254 was originally obtained from the nasal mucosa of a carrier and was first described by Losnegard and Oeding (9) in 1963. Although chemically characterized as containing a-glucosyl glycerol teichoic acid (9), strain 1254 also showed cross-precipitation with a strain of S. aureus (10) . Strain T-2 was characterized by Davison and Baddiley (3) and also Oeding et al. (13) as containing ,-glucosyl glycerol teichoic acid with minor amounts of glucosamine residues. Strain 11997 was reported by Johnsen et al. (7, 8) to contain predominantly ,B-N-acetylglucosamine glycerol teichoic acid with small amounts of a-linked residues. The Lafferty strain of S. aureus is frequently used in clinical assays for teichoic acid antibodies and contains both a-and P-N-acetylglucosamine ribitol teichoic acids (2) . Thus, teichoic acids prepared from this collection of organisms comprise the majority of antigenic types found among coagulase-positive and coagulase-negative staphylococci (13) .
As expected, each strain was found to possess a distinct, antigenic determinant. The preparation from strain 1254 possessed a separate or shared determinant with the S. aureus Lafferty teichoic acid. This appears to be responsible for the similarity in anti-teichoic acid antibody titers detected in the groups of rabbits by both antigens.
Experimental S. epidermidis endocarditis is well suited to the study of the kinetics of the serum antibody response because of the relatively long period of survival of infected animals. In contrast, the mean survival of rabbits with aortic valve endocarditis due to S. aureus is less than 8 days (16, 22 Our study showed that serum IgG anti-teichoic acid antibody appeared after intravenous inoculation of S. epidermidis into rabbits. Antibody titers among catheterized rabbits were greater in culture-positive rabbits than in the culture-negative control groups. There was minimal cross-reactivity with antigens prepared from two other coagulase-negative strains in an ELISA inhibition assay, but major immunological cross-reactivity occurred with S. aureus Lafferty teichoic acid.
The ELISA described herein could be used in the diagnosis of human infections caused by both coagulase-positive and coagulase-negative staphylococci. The teichoic acid antigens chosen cover the range of most staphylococcal infections. The next step in our studies will be to investigate the use of this assay in the confirmation of human staphylococcal infections.
